LLY

822.34

+1.77%↑

UNH

547.41

+1.37%↑

JNJ

152.44

-0.07%↓

ABBV

187.53

+7.26%↑

NVO

84.83

+0.44%↑

LLY

822.34

+1.77%↑

UNH

547.41

+1.37%↑

JNJ

152.44

-0.07%↓

ABBV

187.53

+7.26%↑

NVO

84.83

+0.44%↑

LLY

822.34

+1.77%↑

UNH

547.41

+1.37%↑

JNJ

152.44

-0.07%↓

ABBV

187.53

+7.26%↑

NVO

84.83

+0.44%↑

LLY

822.34

+1.77%↑

UNH

547.41

+1.37%↑

JNJ

152.44

-0.07%↓

ABBV

187.53

+7.26%↑

NVO

84.83

+0.44%↑

LLY

822.34

+1.77%↑

UNH

547.41

+1.37%↑

JNJ

152.44

-0.07%↓

ABBV

187.53

+7.26%↑

NVO

84.83

+0.44%↑

Search

Kala Pharmaceuticals Inc

Closed

9.23 8.46

Overview

Share price change

24h

Current

Min

8.31

Max

9.61

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+69.88 upside

Dividends

By Dow Jones

Next Earnings

28 Mar 2025

Kala Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

30 Jan 2025, 22:05 UTC

Earnings

KLA 2Q Revenue Outpaces Guidance After AI Investment Boost

30 Jan 2025, 21:37 UTC

Earnings

Visa Fiscal 1Q Revenue Rises on Strong Holiday-Season Spending

30 Jan 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Earnings Hopes Continue -- Market Talk

30 Jan 2025, 23:42 UTC

Top News

Nvidia Chip Flow to China Should be Throttled Post-DeepSeek, U.S. Lawmakers Say -- Update

30 Jan 2025, 23:31 UTC

Top News
Earnings

Apple iPhone Sales Shrink Slightly as Investors Await AI Payoff -- 3rd Update

30 Jan 2025, 23:23 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Beach Energy Could Get Aggressive on Deals -- Market Talk

30 Jan 2025, 23:08 UTC

Major Market Movers

Cipher Mining Shares Rise After News of SoftBank Group Investment

30 Jan 2025, 23:06 UTC

Earnings

U.S. Steel Earnings Top the Street. Its Fate Is Still Unknown. -- Barrons.com

30 Jan 2025, 23:06 UTC

Market Talk
Earnings

Apple's Cook: DeepSeek's Open-Source AI Model is a 'Good Thing' -- Market Talk

30 Jan 2025, 23:06 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

30 Jan 2025, 23:00 UTC

Market Talk
Earnings

iPhone 16 Sales Stronger in Regions Where AI Tools Are Available -- Market Talk

30 Jan 2025, 22:47 UTC

Top News

Trump Aides Hunt for 11th-Hour Deal to Dial Back Canada-Mexico Tariffs -- WSJ

30 Jan 2025, 22:40 UTC

Top News

Nvidia Chip Flow to China Should be Throttled Post-DeepSeek, U.S. Lawmakers Say -- WSJ

30 Jan 2025, 22:31 UTC

Top News

OpenAI in Talks for Huge Investment Round Valuing It Up to $300 Billion -- 3rd Update

30 Jan 2025, 22:12 UTC

Top News
Earnings

Apple iPhone Sales Shrink Slightly as Investors Await AI Payoff -- 2nd Update

30 Jan 2025, 21:53 UTC

Earnings

Visa Profit Climbs 5% as Consumer Spending Holds Up -- Barrons.com

30 Jan 2025, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

30 Jan 2025, 21:50 UTC

Market Talk
Earnings

Basic Materials Roundup: Market Talk

30 Jan 2025, 21:47 UTC

Top News
Earnings

Intel Stock Is Volatile After Earnings. There's No Update on a New CEO. -- Barrons.com

30 Jan 2025, 21:45 UTC

Earnings

Apple Beats Earnings Target On Record Services Business -- IBD

30 Jan 2025, 21:43 UTC

Top News
Earnings

Apple iPhone Sales Shrink Slightly as Investors Await AI Payoff -- Update

30 Jan 2025, 21:37 UTC

Top News

Chevron Earnings Are Coming. Why Results Won't Answer All of Investors' Questions. -- Barrons.com

30 Jan 2025, 21:34 UTC

Earnings

Apple Stock Reacts to Earnings -- WSJ

30 Jan 2025, 21:31 UTC

Top News
Earnings

Apple iPhone Sales Shrink Slightly as Investors Await AI Payoff -- WSJ

30 Jan 2025, 21:30 UTC

Top News
Earnings

Visa Profit Climbs 5% as Consumer Spending Holds Up -- Barrons.com

30 Jan 2025, 21:30 UTC

Earnings

Apple 1Q Wearables, Home and Accessories Rev $11.75B >AAPL

30 Jan 2025, 21:30 UTC

Earnings

Apple 1Q Services Rev $26.34B >AAPL

30 Jan 2025, 21:30 UTC

Earnings

Apple 1Q iPhone Rev $69.14B >AAPL

30 Jan 2025, 21:30 UTC

Earnings

Apple 1Q Mac Rev $8.99B >AAPL

30 Jan 2025, 21:30 UTC

Earnings

Apple 1Q iPad Rev $8.09B >AAPL

Peer Comparison

Price change

Kala Pharmaceuticals Inc Forecast

Price Target

By TipRanks

69.88% upside

12 Months Forecast

Average 15 USD  69.88%

High 15 USD

Low 15 USD

Based on 1 Wall Street analysts offering 12 month price targets forKala Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Financials

$